[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618505":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":23,"locations":29,"responsibleParty":60,"collaborators":12,"id":64,"slug":12,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":12,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":12,"overallStatus":83,"whyStopped":12,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Beijing Anzhen Hospital","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care Group","NO_INTERVENTION","Patients receive standard post-PCI management, including guideline-directed medical therapy (GDMT) and routine outpatient follow-up visits at 1, 3, 6, 9, and 12 months.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Digital Remote Management Group","EXPERIMENTAL","1-year intervention:\n\n1. BP Management: Protocol-driven self-monitoring frequencies. The system triggers alerts for BP \\>130\u002F80 mmHg and generates automated suggestions for medication titration, subject to physician approval.\n2. Lipid Management: Automated reminders for laboratory testing. Optical Character Recognition (OCR) technology extracts data from lab reports. If LDL-C ≥1.4 mmol\u002FL, the system proposes regimen intensification for physician review.\n3. Exercise Management:Target of ≥6000 steps\u002Fday. Data is synchronized via wearables or smartphones. Inactivity triggers automated behavioral feedback.\n4. Medication Management: Daily app-based reminders and digital \"check-ins.\" Non-adherence triggers automated alerts followed by human intervention if persistent.\n5. Symptom Monitoring: Patient-reported outcomes (e.g., chest pain\u002Fdyspnea) via the App, with automated triage for risk stratification.\n6. Health Education: Push delivery of targeted secondary prevention educational materials.",[18],"Other: Digital Remote Management Group",[20],{"type":6,"name":14,"description":21,"armGroupLabels":22,"otherNames":12},"1-year intervention\n\n1. BP Management: Protocol-driven self-monitoring frequencies. The system triggers alerts for BP \\>130\u002F80 mmHg and generates automated suggestions for medication titration, subject to physician approval.\n2. Lipid Management: Automated reminders for laboratory testing. Optical Character Recognition (OCR) technology extracts data from lab reports. If LDL-C ≥1.4 mmol\u002FL, the system proposes regimen intensification for physician review.\n3. Exercise Management:Target of ≥6000 steps\u002Fday. Data is synchronized via wearables or smartphones. Inactivity triggers automated behavioral feedback.\n4. Medication Management: Daily app-based reminders and digital \"check-ins.\" Non-adherence triggers automated alerts followed by human intervention if persistent.\n5. Symptom Monitoring: Patient-reported outcomes (e.g., chest pain\u002Fdyspnea) via the App, with automated triage for risk stratification.\n6. Health Education: Push delivery of targeted secondary prevention educational materials.",[14],[24],{"name":25,"role":26,"phone":27,"phoneExt":12,"email":28},"DigiCare-CHD Coordinating Center","CONTACT","13810720787","chshma@vip.sina.com",[30,39,44,52],{"facility":27,"status":12,"city":31,"state":12,"zip":12,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":12},"Beijing","China",{"type":34,"coordinates":35},"Point",[36,37],116.39723,39.9075,{"lat":37,"lon":36},{"facility":40,"status":12,"city":31,"state":12,"zip":12,"country":32,"cosmosGeoPoint":41,"geoPoint":43,"contacts":12},"Beijing Tongren Hospital, Capital Medical University, Beijing, China",{"type":34,"coordinates":42},[36,37],{"lat":37,"lon":36},{"facility":45,"status":12,"city":46,"state":12,"zip":12,"country":32,"cosmosGeoPoint":47,"geoPoint":51,"contacts":12},"The First Affiliated Hospital of Dalian Medical University, Dalian, China","Dalian",{"type":34,"coordinates":48},[49,50],121.60222,38.91222,{"lat":50,"lon":49},{"facility":53,"status":12,"city":54,"state":12,"zip":12,"country":32,"cosmosGeoPoint":55,"geoPoint":59,"contacts":12},"The First Hospital of Jilin University, Changchun, China","Jilin City",{"type":34,"coordinates":56},[57,58],126.5608,43.84652,{"lat":58,"lon":57},{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Chang sheng Ma","Director of cardiology department","100618505",false,"NCT07332494","Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)","DigiCare-CHD","Inclusion Criteria:\n\n1. Age 18-75 years\n2. Diagnosis of Acute Coronary Syndrome (ACS) or Chronic Coronary Syndrome (CCS)\n3. Status post-successful percutaneous coronary intervention (PCI).\n4. Possession of a smartphone and ability to operate the application (independently or with caregiver assistance).\n5. Provision of written informed consent.\n\nExclusion Criteria:\n\n1. Heart Failure: NYHA Class III-IV or LVEF \\\u003C 40%.\n2. Severe hepatic dysfunction (ALT\u002FAST ≥3xULN or Total Bilirubin \\>1.5 mg\u002Fdl)\n3. Severe renal dysfunction (eGFR \\\u003C 30 ml\u002Fmin\u002F1.73m² or requiring dialysis)\n4. Uncontrolled hypothyroidism (TSH \\>1.5xULN or \\>10 mIU\u002FL, or unstable dosage within 6 weeks)\n5. Life expectancy \\\u003C 1 year due to non-cardiovascular comorbidities\n6. Severe sensory (hearing\u002Fvision) or cognitive impairment precluding device use\n7. Conditions affecting adherence (e.g., substance use disorder, history of alcohol abuse)","ALL","18 Years","75 Years",{"count":74,"type":75},792,"ESTIMATED","INTERVENTIONAL",[78],"NA","The DigiCare-CHD study is an investigator-initiated, multicenter, open-label, parallel-group randomized controlled trial. It aims to evaluated the efficacy of a smartphone-based digital remote management platform compared to usual care in achieving dual goal attainment of blood pressure and LDL-cholesterol levels in patients with coronary heart disease following percutaneous coronary intervention.",[81,82],"Coronary Heart Disease","Percutaneous Coronary Intervention","NOT_YET_RECRUITING","2025-12-31",{"date":86,"type":87},"2026-01-12","ACTUAL",{"date":89,"type":75},"2026-01",{"date":91,"type":75},"2027-07",{"name":5,"class":6},4]